 | • レポートコード：MRC2012B1365 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ブドウ球菌感染症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ブドウ球菌感染症治療の種類別市場規模（経口薬、注射液）、用途別市場規模（黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Nymox Pharmaceutical、Viral Genetics、Evolva、Destiny Pharma、TAXIS Pharmaceuticals、Sequoia Sciences ・地域別グローバル市場分析 2015年-2020年 ・ブドウ球菌感染症治療の北米市場（アメリカ、カナダ、メキシコ） ・ブドウ球菌感染症治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ブドウ球菌感染症治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ブドウ球菌感染症治療の南米市場（ブラジル、アルゼンチン） ・ブドウ球菌感染症治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口薬、注射液 ・用途別分析：黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Staphylococcal Infection Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Staphylococcal Infection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Staphylococcal Infection Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Staphylococcal Infection Treatment market has been segmented into:
Oral Medication
Injection Liquid
By Application, Staphylococcal Infection Treatment has been segmented into:
Staphylococcus Aureus Infection
Staphylococcus Epidermis Infection
Saprococcus Infection
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Staphylococcal Infection Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Staphylococcal Infection Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Staphylococcal Infection Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Staphylococcal Infection Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Staphylococcal Infection Treatment Market Share Analysis
Staphylococcal Infection Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Staphylococcal Infection Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Staphylococcal Infection Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Staphylococcal Infection Treatment are:
Nymox Pharmaceutical
Viral Genetics
Evolva
Destiny Pharma
TAXIS Pharmaceuticals
Sequoia Sciences
Among other players domestic and global, Staphylococcal Infection Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Staphylococcal Infection Treatment Market Overview
1.1 Product Overview and Scope of Staphylococcal Infection Treatment
1.2 Classification of Staphylococcal Infection Treatment by Type
1.2.1 Global Staphylococcal Infection Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Staphylococcal Infection Treatment Revenue Market Share by Type in 2019
1.2.3 Oral Medication
1.2.4 Injection Liquid
1.3 Global Staphylococcal Infection Treatment Market by Application
1.3.1 Overview: Global Staphylococcal Infection Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Staphylococcus Aureus Infection
1.3.3 Staphylococcus Epidermis Infection
1.3.4 Saprococcus Infection
1.4 Global Staphylococcal Infection Treatment Market by Regions
1.4.1 Global Staphylococcal Infection Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Staphylococcal Infection Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Staphylococcal Infection Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Staphylococcal Infection Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Staphylococcal Infection Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Staphylococcal Infection Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Staphylococcal Infection Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Nymox Pharmaceutical
2.1.1 Nymox Pharmaceutical Details
2.1.2 Nymox Pharmaceutical Major Business
2.1.3 Nymox Pharmaceutical SWOT Analysis
2.1.4 Nymox Pharmaceutical Product and Services
2.1.5 Nymox Pharmaceutical Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Viral Genetics
2.2.1 Viral Genetics Details
2.2.2 Viral Genetics Major Business
2.2.3 Viral Genetics SWOT Analysis
2.2.4 Viral Genetics Product and Services
2.2.5 Viral Genetics Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Evolva
2.3.1 Evolva Details
2.3.2 Evolva Major Business
2.3.3 Evolva SWOT Analysis
2.3.4 Evolva Product and Services
2.3.5 Evolva Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Destiny Pharma
2.4.1 Destiny Pharma Details
2.4.2 Destiny Pharma Major Business
2.4.3 Destiny Pharma SWOT Analysis
2.4.4 Destiny Pharma Product and Services
2.4.5 Destiny Pharma Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 TAXIS Pharmaceuticals
2.5.1 TAXIS Pharmaceuticals Details
2.5.2 TAXIS Pharmaceuticals Major Business
2.5.3 TAXIS Pharmaceuticals SWOT Analysis
2.5.4 TAXIS Pharmaceuticals Product and Services
2.5.5 TAXIS Pharmaceuticals Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sequoia Sciences
2.6.1 Sequoia Sciences Details
2.6.2 Sequoia Sciences Major Business
2.6.3 Sequoia Sciences Product and Services
2.6.4 Sequoia Sciences Staphylococcal Infection Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Staphylococcal Infection Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Staphylococcal Infection Treatment Players Market Share
3.2.2 Top 10 Staphylococcal Infection Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Staphylococcal Infection Treatment Revenue and Market Share by Regions
4.2 North America Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
5 North America Staphylococcal Infection Treatment Revenue by Countries
5.1 North America Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
5.2 USA Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
6 Europe Staphylococcal Infection Treatment Revenue by Countries
6.1 Europe Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
6.2 Germany Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
6.4 France Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Staphylococcal Infection Treatment Revenue by Countries
7.1 Asia-Pacific Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
7.2 China Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
7.5 India Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
8 South America Staphylococcal Infection Treatment Revenue by Countries
8.1 South America Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
8.2 Brazil Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Staphylococcal Infection Treatment by Countries
9.1 Middle East & Africa Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Staphylococcal Infection Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Staphylococcal Infection Treatment Market Forecast by Type (2019-2024)
10.3 Oral Medication Revenue Growth Rate (2015-2025)
10.4 Injection Liquid Revenue Growth Rate (2015-2025)
11 Global Staphylococcal Infection Treatment Market Segment by Application
11.1 Global Staphylococcal Infection Treatment Revenue Market Share by Application (2015-2020)
11.2 Staphylococcal Infection Treatment Market Forecast by Application (2019-2024)
11.3 Staphylococcus Aureus Infection Revenue Growth (2015-2020)
11.4 Staphylococcus Epidermis Infection Revenue Growth (2015-2020)
11.5 Saprococcus Infection Revenue Growth (2015-2020)
12 Global Staphylococcal Infection Treatment Market Size Forecast (2021-2025)
12.1 Global Staphylococcal Infection Treatment Market Size Forecast (2021-2025)
12.2 Global Staphylococcal Infection Treatment Market Forecast by Regions (2021-2025)
12.3 North America Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
12.6 South America Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Staphylococcal Infection Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Staphylococcal Infection Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Staphylococcal Infection Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Staphylococcal Infection Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Staphylococcal Infection Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Nymox Pharmaceutical Corporate Information, Location and Competitors
Table 7. Nymox Pharmaceutical Staphylococcal Infection Treatment Major Business
Table 8. Nymox Pharmaceutical Staphylococcal Infection Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Nymox Pharmaceutical SWOT Analysis
Table 10. Nymox Pharmaceutical Staphylococcal Infection Treatment Product and Solutions
Table 11. Nymox Pharmaceutical Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Viral Genetics Corporate Information, Location and Competitors
Table 13. Viral Genetics Staphylococcal Infection Treatment Major Business
Table 14. Viral Genetics Staphylococcal Infection Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Viral Genetics SWOT Analysis
Table 16. Viral Genetics Staphylococcal Infection Treatment Product and Solutions
Table 17. Viral Genetics Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Evolva Corporate Information, Location and Competitors
Table 19. Evolva Staphylococcal Infection Treatment Major Business
Table 20. Evolva Staphylococcal Infection Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Evolva SWOT Analysis
Table 22. Evolva Staphylococcal Infection Treatment Product and Solutions
Table 23. Evolva Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Destiny Pharma Corporate Information, Location and Competitors
Table 25. Destiny Pharma Staphylococcal Infection Treatment Major Business
Table 26. Destiny Pharma Staphylococcal Infection Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Destiny Pharma SWOT Analysis
Table 28. Destiny Pharma Staphylococcal Infection Treatment Product and Solutions
Table 29. Destiny Pharma Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. TAXIS Pharmaceuticals Corporate Information, Location and Competitors
Table 31. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Major Business
Table 32. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Total Revenue (USD Million) (2017-2018)
Table 33. TAXIS Pharmaceuticals SWOT Analysis
Table 34. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Product and Solutions
Table 35. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Sequoia Sciences Corporate Information, Location and Competitors
Table 37. Sequoia Sciences Staphylococcal Infection Treatment Major Business
Table 38. Sequoia Sciences Staphylococcal Infection Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Sequoia Sciences SWOT Analysis
Table 40. Sequoia Sciences Staphylococcal Infection Treatment Product and Solutions
Table 41. Sequoia Sciences Staphylococcal Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Staphylococcal Infection Treatment Revenue (Million USD) by Players (2015-2020)
Table 43. Global Staphylococcal Infection Treatment Revenue Share by Players (2015-2020)
Table 44. Global Staphylococcal Infection Treatment Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Staphylococcal Infection Treatment Revenue Market Share by Regions (2015-2020)
Table 46. North America Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
Table 47. North America Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Europe Staphylococcal Infection Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Staphylococcal Infection Treatment Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Staphylococcal Infection Treatment Revenue by Countries (2015-2020)
Table 51. South America Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Staphylococcal Infection Treatment Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Table 54. Global Staphylococcal Infection Treatment Revenue (Million USD) by Type (2015-2020)
Table 55. Global Staphylococcal Infection Treatment Revenue Share by Type (2015-2020)
Table 56. Global Staphylococcal Infection Treatment Revenue Forecast by Type (2021-2025)
Table 57. Global Staphylococcal Infection Treatment Revenue by Application (2015-2020)
Table 58. Global Staphylococcal Infection Treatment Revenue Share by Application (2015-2020)
Table 59. Global Staphylococcal Infection Treatment Revenue Forecast by Application (2021-2025)
Table 60. Global Staphylococcal Infection Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Staphylococcal Infection Treatment Picture
Figure 2. Global Staphylococcal Infection Treatment Revenue Market Share by Type in 2019
Figure 3. Oral Medication Picture
Figure 4. Injection Liquid Picture
Figure 5. Staphylococcal Infection Treatment Revenue Market Share by Application in 2019
Figure 6. Staphylococcus Aureus Infection Picture
Figure 7. Staphylococcus Epidermis Infection Picture
Figure 8. Saprococcus Infection Picture
Figure 9. Global Staphylococcal Infection Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Staphylococcal Infection Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Staphylococcal Infection Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Staphylococcal Infection Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Staphylococcal Infection Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Staphylococcal Infection Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Staphylococcal Infection Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Staphylococcal Infection Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Staphylococcal Infection Treatment Revenue Market Share by Countries in 2019
Figure 42. China Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Staphylococcal Infection Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Staphylococcal Infection Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Staphylococcal Infection Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Staphylococcal Infection Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Staphylococcal Infection Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Staphylococcal Infection Treatment Revenue Share by Type in 2019
Figure 59. Global Staphylococcal Infection Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Medication Revenue Growth Rate (2015-2020)
Figure 61. Global Injection Liquid Revenue Growth Rate (2015-2020)
Figure 62. Global Staphylococcal Infection Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Staphylococcal Infection Treatment Revenue Share by Application in 2019
Figure 64. Global Staphylococcal Infection Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Staphylococcus Aureus Infection Revenue Growth Rate (2015-2020)
Figure 66. Global Staphylococcus Epidermis Infection Revenue Growth Rate (2015-2020)
Figure 67. Global Saprococcus Infection Revenue Growth Rate (2015-2020)
Figure 68. Global Staphylococcal Infection Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Staphylococcal Infection Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Staphylococcal Infection Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Staphylococcal Infection Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
耳感染症治療の世界市場（～2026年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
- クロストリジウム・ディフィシル感染症治療の世界市場（～2026年） Clostridium difficile is one of the most common hospital acquired infections and in the last decade, there has been a notable increase in the incidence of clostridium difficile infection as well as the severity of the infection owing to recurrence and antibiotic resistance. Disproportionately higher…